AGCO vs REGN · rev $4.95B vs P/E 14, rev $4.29B
AGCO Corporation (AGCO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AGCO Corporation (AGCO) is a farm & heavy construction machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AGCO revenue for 2026-06-30 was $4.95B. Net income was $132.2M. AGCO currently screens at market cap $8.25B.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AGCO currently screens at market cap $8.25B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AGCO and REGN stock pages for the full models.
Not investment advice.